Since CXCR4 appears to have an important role in the pathogenesis and progression of pancreatic cancer [1], [2], [3], our work has important clinical implications in the identification of a novel therapeutic use for these established anti-malarial agents. The gene discussed is CXCR4; the disease is pancreatic neoplasm.